The second consignment of 2.5 million doses of Corona vaccine Covaxin of Hyderabad-based company Bharat Biotech came out of the factory on Friday morning. It will go to 22 cities of the country including Delhi, Mumbai. This is expected to give further momentum to vaccination. Earlier on January 13, the first consignment of 2.4 lakh doses from Bharat Biotech reached 11 cities in the country. Bharat Biotech has received an order of 55 lakh doses from the Central Government. This second consignment is his second installment.
Covaxin of Bharat Biotech as well as Covishield of Serum Institute of India are being used in the vaccination started in India on 16 January.
A source associated with Bharat Biotech told news agency IANS that a second shipment of covaxin has been sent to 22 cities on Friday morning. The vaccine dose will reach its destination by Saturday morning. According to the information so far, 25,66,860 doses in 1,28,343 vials have left from the factory. There are 20 doses in every 10 ml bottle. The vaccine will arrive from Hyderabad to Government Medical Store depots located in Chennai, Karnal, Kolkata, and Mumbai. The indigenous vaccine will reach Ganaavaram, Kurukshetra, Patna, Lucknow, Guwahati, Kolkata Salt Lake, Jaipur, Gandhi Nagar, and Bhopal in Andhra Pradesh. Apart from this, some doses will also go to Delhi, Raipur, Ranchi, Thiruvananthapuram, Chandigarh, Bengaluru, Pune, Bhubaneswar, and Hyderabad.
Covaxin is surrounded by controversies
Covaxin has been mired in controversies ranging from emergency approval to vaccination. The data for phase-3 trials of the vaccine was not revealed and its efficacy is not known. Trials of Phase-1 and Phase-2 reveal their safety and ability to produce immune responses. Many scientists and doctors had spoken of not applying covaxin before the efficacy data came out. Due to this, even doctors in priority groups are seen to be avoiding covaxin.
India's first indigenous corona vaccine
Covaxin is India's first indigenous corona vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The inactivated virus vaccine is being developed and manufactured in Bharat Biotech's BSL-3 (Biosafety Level 3) biocontainment facility.
Covishield will leave for Myanmar, Seychelles, and Mauritius
The consignment from Corona Vaccine Covishield's Serum Institute of India (SII) will leave for Myanmar, Seychelles, and Mauritius. It reached Chhatrapati Shivaji Maharaj International Airport in Mumbai on Friday morning. 15 lakh doses of Myanmar, 1 lakh doses of Mauritius, and 50 thousand doses of seashells. Earlier, India's Foreign Ministry had announced to send vaccine doses for Bhutan, Maldives, Bangladesh, Nepal, Myanmar, and Seychelles from Wednesday. This vaccine is being sent based on Neighborhood First Policy ie First Neighbor Policy.
Spider-Man: Across the Spider-Verse: On June 2, 2023, the sequel to the animated film 'Spider-Man
The world has not recognized the Taliban regime that seized power in Afghanistan about 16 months
After the consecration of Ramlala, there is going to be a change in his worship and aarti. The en
Weather Update: It is raining in many parts of the country along with snowfall in the mountains.
MP Rahul Gandhi has reached Chandigarh today to prepare a roadmap for the expansion of the organi
Delhi Capitals spinner Akshar Patel believes that the introduction of the Impact Player rule in t
The Online Gaming Promotion and Regulation Bill, 2025, has now become a law after the President's
Another shooter involved in the Umesh Pal murder case was killed by the police in an encounter on
Vijay Mallya contempt case: Supreme Court to hear last on January 18, said - have waited a lot
The Supreme Court made an important announcement on Tuesday in the contempt case against Vijay Ma
Union Minister of State for Education Sukanta Majumdar on Wednesday told Parliament that the thre
